| Theme |
Biliopancreatic Drainage and Stenting |
| Title |
Endoscopic Transpapillary Treatment for Pancreatic Pseudocysts |
| Author |
Toshiharu Ueki |
Department of Gastroenterology, Fukuoka University Chikushi Hospital |
| Author |
Toru Maruo |
Department of Gastroenterology, Fukuoka University Chikushi Hospital |
| Author |
Kei-ichiro Matsumura |
Department of Gastroenterology, Fukuoka University Chikushi Hospital |
| Author |
Ryohei Minoda |
Department of Gastroenterology, Fukuoka University Chikushi Hospital |
| Author |
Ken-ichiro Kawamoto |
Department of Gastroenterology, Fukuoka University Chikushi Hospital |
| Author |
Toshiyuki Matsui |
Department of Gastroenterology, Fukuoka University Chikushi Hospital |
| [ Summary ] |
Endoscopic taranspapillary treatment is primarily performed for treatment of pancrestic pseudocysts. Endoscopic taranspapillary drainage is indicated in patients with pseudocysts communicating with the pancreatic duct and increasing pseudocysts with symptoms, infected psudocysts, or ruptured pseudocysts with/without pancreatic ascites and pleural effusion.
Endoscopic transpapillary treatment for pancreatic pseudocysts includes endoscopic nasocystic drainage (ENCD) and endoscopic nasopancreatic drainage (ENPD), as well as endoscopic cystic stenting (ECT) and endoscopic pancreatic stenting (EPT). Endoscopic cystic stents (ECS) and endoscopic pancreatic stents（EPS）are inset at one to two weeks after ENCD and ENPD. ECS and EPS are done alternately every three months, and removed about one year after insertion. In patients with unsuccessful pseudocysts who have been treated with endoscopic transpapillary drainage, endoscopic transmural drainage, percutaneous drainage, and surgical drainage should be considered. |